Meningitis Foundation calls for PHARMAC to protect everyone

15 November 2019 - Following PHARMAC’s announcement stating the meningococcal ACWY vaccine will be available free from next month for ...

Read more →

PHARMAC widening access to the meningococcal ACWY vaccine

14 November 2019 - The meningococcal ACWY vaccine will be available free from next month for young people in close ...

Read more →

Merck’s Ervebo [Ebola Zaire vaccine (rVSVΔG-ZEBOV-GP) live] granted conditional approval in the European Union

12 November 2019 - Authorisation represents significant advancement in the global response to Ebola. ...

Read more →

Johnson & Johnson announces submission of European marketing authorisation applications for Janssen’s investigational Ebola vaccine regimen

7 November 2019 - Data from multiple preclinical, Phase 1, 2 and 3 studies support applications, which have been granted Accelerated ...

Read more →

FDA approves Fluzone High-Dose quadrivalent (influenza vaccine) for adults 65 years of age and older

4 November 2019 - Will be available in fall 2020, in time for the 2020-2021 flu season. ...

Read more →

Report clearly demonstrates the value of vaccines

1 November 2019 - Medicines Australia welcomes today’s report from the Australian Institute of Health and Welfare which verifies the ...

Read more →

New Zealand Pharmaceutical Schedule - 1 November 2019

1 November 2019 - The November 2019 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

Benefit payments for Australian father cut while son receives cancer treatment

24 October 2019 - A Perth father has reportedly lost his Family Tax Benefit cut because his son wasn't vaccinated. ...

Read more →

Merck receives EU CHMP positive opinion for investigational V920 Ebola Zaire vaccine for protection against Ebola virus disease

18 October 2019 - Merck today announced that the CHMP of the EMA has adopted a positive opinion recommending a conditional ...

Read more →

Complexity in assessing the benefit versus risk of vaccines: experience with rotavirus and dengue virus vaccines

17 October 2019 - The remarkable contribution of immunisation programs to public health is recognised by most people, including those who ...

Read more →

First Algenex CrisBio-based vaccine submitted to European Medicines Agency

15 October 2019 - Potential approval would validate the use of Algenex’ CrisBio technology for the manufacture of recombinant subunit vaccines. ...

Read more →

Emergent BioSolutions receives EMA Prime Designation for its Chikungunya virus vaccine candidate

10 October 2019 - Emergent BioSolutions today announced that the company’s chikungunya virus (CHIKV) virus-like particle (VLP) vaccine candidate, CHIKV VLP, ...

Read more →

FDA approves first live, non-replicating vaccine to prevent smallpox and monkeypox

24 September 2019 - The U.S. FDA announced today the approval of Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, for the ...

Read more →

FDA accepts Merck’s biologics license application and grants priority review for V920, the company’s investigational vaccine for Ebola Zaire virus

17 September 2019 - Merck continues to expand investigational supply to support international Ebola outbreak response. ...

Read more →

PHARMAC may have to compete for measles vaccine

17 September 2019 - PHARMAC is looking at whether it can order more measles vaccine in case the latest batch runs ...

Read more →